Cellebrite DI .(CLBT)
搜索文档
Cellebrite DI .(CLBT) - 2022 Q3 - Quarterly Report
2022-11-17 00:00
Exhibit 99.1 Cellebrite Announces Third Quarter 2022 Results ARR of $232 million, up 35% year-over-year Third Quarter revenue of $71.7 million, Increase 9% year-over-year PETAH TIKVA, ISRAEL, and TYSONS CORNER, VA, November 17, 2022 – Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three and nine months ending September 30, 2022. "We are pleased to report a solid third quarter, delivering strong ...
Cellebrite DI .(CLBT) - 2022 Q2 - Quarterly Report
2022-09-13 00:00
Exhibit 99.1 Cellebrite DI Ltd.and its Subsidiaries INTERIM CONSOLIDATED BALANCE SHEETS (U.S Dollars in thousands, except share and per share data) INTERIM CONSOLIDATED BALANCE SHEETS U.S. dollar in thousands (except share and per share data) CONSOLIDATED FINANCIAL STATEMENTS CELLEBRITE DI LTD. AND ITS SUBSIDIARIES INTERIM CONSOLIDATED FINANCIAL STATEMENT AS OF JUNE 30, 2022 UNAUDITED INDEX | --- | --- | |----------------------------------------------------------------------------------|-------| | | Page | ...
Cellebrite DI .(CLBT) - 2022 Q2 - Earnings Call Transcript
2022-08-12 02:24
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Anat Earon-Heilborn - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Mike Cikos - Needham & Company Jonathan Ho - William Blair & Company Shaul Eyal - Cowen Jamie Shelton - Deutsche Bank Louie DiPalma - William Blair & Company Operator Good day and thank you for standing by. Welcome to the Cellebrite Q2 ...
Cellebrite DI (CLBT) Investor Presentation - Slideshow
2022-06-04 02:33
:: Cellebrite Investor Presentation May 2022 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-BAAP financial measures. Cellebrite believes hat lhese non-BAAP mossures are useful to investors for two principal reasons. First, Dollohrid investors in comparing performance over various reporting periods on a consisient basis by removing from operaling results te impact of liems that do not reflect ore opera measures are used by Cellebrite s management to assess is performance. Celebr ...
Cellebrite DI .(CLBT) - 2022 Q1 - Earnings Call Transcript
2022-05-12 23:26
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Anat Earon-Heilborn - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Tomer Zilberman - Bank of America Merrill Lynch Jamie Shelton - Deutsche Bank Louie DiPalma - William Blair & Company Operator Good day and thank you for standing by. Welcome to the Cellebrite Q1 '22 Earnings Call. At this time, all parti ...
Cellebrite DI .(CLBT) - 2022 Q1 - Earnings Call Presentation
2022-05-12 21:44
් Cellebrite Q1 '22 Earnings Call 12 May 2022 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-GAAP financial measures. Cellebrite believes that these non-GAAP measures are useful to investors for two principal reasons. First, Collebri believes these measures may assist investors in comparing performance over various reporting periods on a consistent basis by removing from operating results he impact of items that do not reflect core operating performance. Second, these measures ...
Cellebrite DI .(CLBT) - 2022 Q1 - Quarterly Report
2022-05-12 00:00
Exhibit 99.1 Cellebrite Announces First Quarter 2022 Results ARR of $201 million, up 33% year-over-year First Quarter revenue of $62.4 million, up 17% year-over-year Reiterates 2022 outlook for 34-42% ARR growth and 16-22% revenue growth PETAH TIKVA, ISRAEL, and TYSONS CORNER, VA, May 12, 2022 – Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three months ended March 31, 2022. "We are excited to ...
Cellebrite DI .(CLBT) - 2021 Q4 - Annual Report
2022-03-29 19:32
Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...
Cellebrite DI .(CLBT) - 2021 Q4 - Earnings Call Presentation
2022-02-22 17:53
් Cellebrite Q4 '21 Earnings Call 16 February 2022 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-GAAP financial measures. Cellebrite believes that these non-GAAP measures are useful to investors for two principal reasons. First, Collebri believes these measures may assist investors in comparing performance over various reporting periods on a consistent basis by removing from operating results he impact of items that do not reflect core operating performance. Second, these meas ...
Cellebrite DI .(CLBT) - 2021 Q4 - Earnings Call Transcript
2022-02-17 01:47
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2021 Results Conference Call February 16, 2022 8:30 AM ET Company Participants Anat Earon-Heilborn - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Jonathan Ho - William Blair Mike Cikos - Needham Shaul Eyal - Cowen Jamie Shelton - Deutsche Bank Louie DiPalma - William Blair Tal Liani - Bank of America Operator Good day and thank you for standing by. Welcome to Cellebrite Fourth ...